N
INSP icon

Numerai’s Inspire Medical Systems INSP Stock Holding History

Numerai’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,543
Closed -$411K – 679
2025
Q3 		$411K Buy
+5,543
New +$561K 0.06% 373

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Numerai's INSP Position: Q4 2025 in Review

Numerai sold out of Inspire Medical Systems (INSP) in Q4 2025, closing a stake of 5,543 shares — an estimated $411K sold.

Numerai first reported a position in INSP in Q3 2025 and held it in 1 quarter. The position peaked at $411K in Q3 2025. 342 funds tracked by Wall St. Rank hold INSP as of Q4 2025.

  • Numerai reported no remaining Inspire Medical Systems position as of Q4 2025 after selling out during the quarter.
  • Numerai sold 5,543 Inspire Medical Systems shares in Q4 2025, an estimated $411K.
  • Numerai first reported a position in Inspire Medical Systems in Q3 2025 and held it in 1 quarter.
  • Numerai's Inspire Medical Systems position peaked at $411K in Q3 2025.
  • 342 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2025.

Based on Numerai's 13F filing for Q4 2025, filed 17 Feb 2026.